Starpharma Holdings Limited (AU:SPL) has released an update.
Starpharma Holdings Limited, an Australian biotechnology firm, has released its Appendix 4G and Corporate Governance Statement, complying with the ASX Listing Rules. The company specializes in dendrimer technology to improve health outcomes in significant illnesses, including cancer, and boasts a portfolio of clinical-stage assets and OTC products. Details of the corporate governance disclosures can be found on the company’s website.
For further insights into AU:SPL stock, check out TipRanks’ Stock Analysis page.
